Hypertensive nephropathy epidemiology and demographics

	Hypertensive nephropathy Microchapters
Home
Patient Information
Overview
Classification
Pathophysiology
Differentiating Hypertensive Nephropathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Abdominal X Ray
CT
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hypertensive nephropathy epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hypertensive nephropathy epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hypertensive nephropathy epidemiology and demographics
CDC on Hypertensive nephropathy epidemiology and demographics
Hypertensive nephropathy epidemiology and demographics in the news
Blogs on Hypertensive nephropathy epidemiology and demographics
Directions to Hospitals Treating Hypertensive nephropathy
Risk calculators and risk factors for Hypertensive nephropathy epidemiology and demographics

Overview

The incident counts and adjusted rates for hypertensive renal disease has been increasing over the past three decades.

More than 20% of patients with systemic hypertension have chronic renal insufficiency.
The prevalence of hypertensive nephropathy among those with hypertension is 24.6%.
The rate of end stage renal disease due to hypertension, while down 2.2 % in 2010, is 7.7 % higher than that in the year 2000.

Hypertensive renal disease has a higher prevalence in those who are aged 65 years and older.